ARTICLE
Auteur(s) : Ana
Maria Abreu Velez1, Michael S Howard1,
Takashi Hashimoto2
1Georgia Dermatopathology Associates, 1534 North
Decatur Road, NE; Suite 206, Atlanta, GA 30307-1000, USA
2Department of Dermatology, Kurume University
School of Medicine, Kurume, Japan
accepté le 17 Septembre 2009
Endemic pemphigus foliaceus (EPF) is the only known endemic
autoimmune disease, and occurs in geographically restricted, rural
regions of South and Central America, as well as in North Africa
[1-3]. The geographically restricted foci of the disorder present
an excellent natural model for studying the interaction of
environment, patient genetic background and patient host immune
responses in disease pathophysiology [1]. We previously described a
new variant of EPF, resembling Senear-Usher syndrome, in El Bagre,
Colombia, South America (El Bagre-EPF) [2]. The El Bagre EPF
variant differs from other EPF variants in many clinical features
[2]. Although all EPF variants are endemic, Brazilian fogo selvagem
(FS) affects both sexes equally, shows its highest incidence of
onset at 10-30 years of age, and indicates antigenic
predominance towards desmoglein 1 (Dsg1) [1]. The Tunisian
variant of endemic pemphigus displays many herpetiform clinical
presentations, and seems to affect predominatly females [3]. In
contrast, Colombian El Bagre-EPF affects predominantly males from
40-60 years of age, as well as a few post-menopausal females;
the patient serum in this variant recognizes plakin molecules, as
well as Dsg1, desmoglein 3, bullous pemphigoid antigens, and other
unknown antigens [2].
Several autoimmune skin diseases and genodermatoses with
desmosome association involve the palms and soles [4-6, 8]. EPF and
sporadic pemphigus foliaceus (PF) seem clinically quite different
from many other autoimmune disorders, in that they lack visible
blisters and erosions in these areas [7]. For example, pemphigus
vulgaris (PV) preferentially affects the mucosal surfaces, and
sometimes produces blisters and extensive exfoliation on the palms
and soles [7]. The cause of this disease phenomenon is not yet well
characterized, although several interesting studies and theories
have been described. Moreover, glabrous skin, non-glabrous skin and
mucosa seem to be constitutionally different in regards to
desmosomes and other types of cell junctions [7]. Thus, based on
our observation that El Bagre-EPF patients present pathologically
edematous skin on the soles and palms with no apparent blisters,
vesicles or erosions, we searched for any subclinical,
pathophysiological changes in the palms of El Bagre EPF patients by
direct immunofluorescence (DIF).
Materials and methods
Subjects
We studied 20 patients who fulfilled the criteria of El
Bagre-EPF, as described previously, and who were followed by us for
over a decade [2]. Patient consents were obtained with
Institutional Review Board permission. Using classical indirect
immunofluorescence (IIF) as described by Beutner et al. [9],
patients were considered positive if they had intercellular
staining between epidermal keratinocytes, especially with
anti-human IgG4 monoclonal antibodies, as well as positive
basement membrane zone (BMZ) staining in some cases [1, 2]. In
addition to these criteria, the patients lived in the endemic area,
and their sera immunoprecipitated a 45 kDa bovine tryptic
fragment of the ectodomain of Dsg1 [2]. Sera from all patients and
controls were also tested by immunoblotting (IB) using human
epidermal extracts, as previously described [1, 2]. For all of our
above determinations, serum from a well-characterized PF patient
located outside the El Bagre EPF endemic area was used as a
positive control. In brief, following local anesthesia without
epinephrine, skin biopsies were taken from clinically unaffected
palms and kept either in 10% buffered formalin (for H & E
examination) or in Michel’s transport medium (Newcomer Supply,
Middleton, Wisconsin, USA) for DIF. The soles were not biopsied as
many of our patients lacked transportation and thus needed to walk
for several hours following the biopsy procedure. We were careful
not to include any patients affected by a clinical palmoplantar
keratoderma (PPK). The controls were matched to the patients by
sex, age and working conditions.
Direct immunofluorescence (DIF)
For DIF, four um thick skin cryosections were partially fixed with
paraformaldehyde, rinsed in phosphate-buffered saline (PBS, pH 6.8)
incubated with fluorescein isothiocyanate (FITC) in a
solubilization buffer (PBS with 0.5% Triton
X-100 Octylphenolpoly (ethyleneglycolether)), and then rinsed.
After blocking with PBS with 0.01%-Tween 20 (Polysorbate 20)
and 0.5% bovine serum albumin (BSA), the sections were incubated
with antiserum for one hour. We used FITC-conjugated rabbit
antisera against fibrinogen and albumin at 1:40 dilution.
These antisera, as well as FITC-conjugated rabbit anti-human IgG
(gamma chain) and IgA (alpha chain) antisera (both
1:20 dilution) and FITC-conjugated rabbit anti-human IgM
(Mu-chain) antiserum were purchased from Dako (Carpinteria,
California, USA). Goat anti-human IgE (Epsilon-chain) antiserum,
conjugated with FITC, was obtained from Vector Laboratories, Inc.,
Burlingame, California, USA. Goat antisera FITC conjugated to human
C1q and human IgD was obtained from Southern Biotech (Birmingham,
Alabama, USA). Anti-human IgD antiserum was absorbed with human
IgG, IgM, and IgA. In addition, we used anti-intercellular adhesion
molecule 1 (ICAM-1/CD54) antibody (Lab Vision
Corporation, Thermo Fisher, Fremont, California, USA) and
anti-junctional adhesion molecule (JAM-A) antibody (Invitrogen,
Carlsbad, California, USA) (recognizing type I transmembrane
glycoproteins of the immunoglobulin superfamily that are localized
in the tight junctions). The slides were then counterstained with
4′,6-diamidino-2-phenylindole(DAPI) (Pierce, Rockford, Illinois,
USA), washed, coverslipped and dried overnight at
4 °C. Other antibodies used included secondary
donkey anti-mouse IgG heavy and light chains (H + L) antiserum
conjugated with Alexa Fluor® 555 (Invitrogen) for
ICAM-1/CD54, utilized to determine potential co-localization of
patient autoantibodies to vessels. In order to determine
co-localization between nerves and El Bagre EPF patient
autoantibodies, we also used simultaneous staining with monoclonal
anti-glial fibrillary acidic protein (GFAP) (Clone GA-5,
Cy3-conjugated, (Sigma Aldrich, Saint Louis, Missouri, USA), at a
dilution of 1:150. We also used mouse anti-human neuron specific
enolase (NSE) monoclonal antibody (at 1:40 dilution, also from
Dako), and, as a secondary antibody, we utilized Texas
red-conjugated sheep anti-mouse IgG (H & L) antiserum
(Rockland Immunochemicals, Inc., Gilbertsville, Pennsylvania,
USA) at 1:100 dilution. Finally, the sections were
examined with a Nikon Eclipse 50i microscope (Tokyo, Japan) using a
Xenon arc light (XBO 75W) as the light source and a plane
achromatic (PL Apo) × 40/0.80 dry objective. The fluorescent
staining was graded as follows: – (negative), ± (doubtful), +
(weak), ++ (moderate), and +++ (bright). The slides were then
examined using Nikon triple filters, i.e., DAPI/FITC/TEXAS RED (EX
395-410/490-505/560-585 nm, EM
450-490/515-545/600-652 nm).
Statistical analysis
A paired-sample t-test was used to analyze the data, with MedCal
software Version 9.6.4.0-©1993-2008, Broekstraat 52,
9030 (Mariakerke, Belgium). Standard deviation with a 95%
confidence interval (CI) was determined.
Results
Hematoxylin and eosin findings on palms
Similar patterns were found in most of the cases of El Bagre-EPF.
The most common findings included epidermal spongiosis, variable
necrotic keratinocytes along the BMZ, and a mild, superficial,
perivascular dermal infiltrate of lymphocytes and histiocytes.
Melanin pigment dropout was noted in the superficial papillary
dermis in most patients. In addition, we consistently observed a
mildly hyperkertotic epidermal stratum corneum; moderate, diffuse
edema in both the papillary and reticular dermis, and variable
degrees of deep dermal perivascular, perineural, and perieccrine
sweat gland infiltration by lymphocytes and histiocytes.
Direct immunofluorescence studies on palms
No controls from the endemic area were positive by DIF, with two
exceptions that each showed some intra-cytoplasmic staining in
patchy areas of the epidermal keratinocytes using C1q. (++). We
characterized the positive patterns of DIF as follows: 1) DIF cell
surface, or intercellular cell staining between epidermal
keratinocytes (ICS). The ICS pattern was noted when using anti
human IgE, IgG, IgM, C3c, albumin and fibrinogen, and in some cases
with IgA and IgD. 2) Basement membrane zone (BMZ) staining, in a
linear, a lupus-band like pattern. The BMZ linear pattern was
primarily observed when utilizing C3 or C3d, IgM, albumin and
fibrinogen. 3) Positive staining of the sweat glands, including the
gland coils and the acrosyringia, was found with IgE, IgM, IgG, and
especially strongly at the acrosyringium with C1q. 4) Positive
staining on neurovascular units, especially within nerve structures
per se, and occasionally within the perineurium, epineurium, and/or
endoneurium areas, as well as within some mechanoreceptors. The
neurovascular staining was seen primarily with IgM, C3c, IgA,
albumin and fibrinogen. 5) Within the epidermal keratinocytes,
positive staining was observed in perinuclear, cytoplasmic and/or
peri-plasma membrane locations; this staining was noted with
albumin, C1q, IgM, albumin and fibrinogen. 6) A strong
immunoreactivity was observed to the superficial, intermediate and
the deep dermal blood vessels. This positivity was observed using
IgG, IgA, C1q, IgM, albumin and fibrinogen. 7) A dermal smooth
muscle a) granular intra-myocyte pattern, and b)
intercellular-junction-like pattern was seen, especially with IgG,
albumin and fibrinogen (figures 1 and 2). As
shown in table 1, the most common
patterns were those of reactivity to the sweat glands, to the
dermal blood vessels, to the BMZ and, to a lesser extent, to the
epidermal keratinocyte intercellular surfaces (ICS). Of interest is
the fact that the ICS was often inconsistently distributed
throughout the epidermis, varying with the immunoglobulin
tested.
Table 1 The most common patters of detection of
autoantibodies in the case El Bagre EPF cases versus the controls
|
Immunological findings by DIF
|
El Bagre-EPF
|
Controls endemic area
|
|
DIF Intercellular cell keratinocyte surface (ICS)
|
IgG (++), (70%), C3 and rare IgA and IgM, albumin (++) (70%).
|
Negative
|
|
DIF BMZ (Lupus-band like)
|
IgG (++) (58%), albumin (++) (85%), fibrinogen (+++)(95%), IgM (++)
(40%), IgA (+++) (34%).
|
Negative
|
|
DIF sweat glands acrosyringium
|
IgG (++) (38%), albumin (+) (38%), fibrinogen (++) (40%), IgM (+)
(20%), IgE, C3, C1q (+/−) (20%)
|
Albumin (+/) (15%), fibrinogen (+/–) (15%)
|
|
DIF Sweat glands coiled portion
|
IgG (++) (38%), albumin (+) (38%), fibrinogen (++) (40%), C3 (++)
345)
|
Negative
|
|
DIF nerves bundles and or mechanoreceptors (Abreu et al., ms
submitted)
|
IgA (++) (34%), ICAM-1 (++) (43%), IgM (++) (34%), albumin (++)
(35%), fibrinogen (+++) (35%),
|
Negative
|
|
Pery-nuclear, some cytoplasmic and/or peri-plasma membrane. This
was mostly granular.
|
Albumin (++) (70%), IgM (++) (30%), IgG (++) (50%).
|
Albumin (+/–) (13%), IgM (+/–) (13%), fibrinogen (+) (15%)
|
|
Superficial and deep vessels
|
Fibrinogen (++) (90%), ICAM-1 (++) (73%), IgA (++) (28%), IgM (++),
C3 (++) (30%), IgG (++) (50%), JAM-A (25%), IgE, C3, C1q (+) (20%).
IgD (+) (20%)
|
ICAM-1 (+/–) or (–) 100%, IgD (+) (20%)
|
|
Deep muscle granular intra-myocyte patterns
|
IgA (++) (28%), IgM (++) (30%), fibrinogen (+) (30%),
|
Negative
|
|
Deep muscle intercellular-like junction pattern
|
Fibrinogen (++) (50%), albumin (++) (50%) IgG (++) 35%
|
Fibrinogen ((+/) (10%), (+/) (10%), albumin
|
Polyclonality of the immune response in palms
by DIF
Of particular interest was the polyclonality of the immune
response. Specifically, a consistent band-like staining was clearly
visualized, especially when using anti-albumin and anti-fibrinogen
anti-sera. The bands resembled those seen in lichen planus, but
instead of being located within the dermis, the bands were observed
throughout the epidermis. The bands seemed to extend from the BMZ
upward into the epidermal stratum spinosum. In figure 1, we show several
representative pictures of this phenomenon. Figure 1A shows a clinical
photograph of an El-Bagre EPF patient. Figures 1B-I shows
immunostaining observed in the palms of El Bagre EPF patients i.e.,
shaggy deposition of fibrinogen at the BMZ and cytoplasmic staining
in keratinocytes for albumin and C3. These patterns seemed to form
a complex net pattern that intersects or overlaps at some axis
points, like some types of cell junctions (figure 1G).
In figures 2A to
E, we show representative positive DIF staining for
fibrinogen (A and B), albumin (C and D) and C3 (E), displaying
a funnel-shaped staining in the acrosyringium and BMZ of sweat
glands (red arrows). In figures 2F, G, H and I, we
show round, positive IgD staining structures close to the blood
vessels. These vesicle-like structures were visualized under 1000×
magnification (red arrows). In figure 2H, the yellow arrow
displays positive co-localization with the blood vessels, as
indicated by positive JAM-A staining (in red). These findings
suggest disease autoreactivity to blood vessels in El
Bagre-EPF.
Figure 3 also
summarizes representative patterns of staining detected in blood
vessels in the superficial and deep dermis, as well as in dermal
muscle and nerve bundles. We detected co-localization of blood
vessel or nerve markers with El Bagre-EPF disease auto-antibodies,
indicating that these structures may play a role in the
pathophysiology of the disease. In the DIF results, we found a
statistically significant difference in the disease cases versus
the controls (p > 0.05). In several patients, we detected
intracytoplasmic autoreactivity to myocytes, especially for IgM. In
agreement with the DIF findings, we visualized H&E
lymphohistiocytic inflammation around the dermal nerve bundles,
blood vessels and sweat glands. In figure 3I, we detected
co-localization of the El Bagre EPF disease antibodies to
fibrinogen, albumin and C3 with neurovascular structures
exhibiting positive staining with NSE.
Discussion
Hereditary skin disorders caused by desmosomal gene pathology may
preferentially involve the palms and soles [6-8]. Indeed, even in
normal control skin, it has been previously demonstrated that
differences in desmosome number, size and/or structural
organization may exist in palmoplantar sites compared to skin from
other body regions [6-8]. Further, confocal microscopy of skin
biopsy material from glabrous and non-glabrous skin has shown
relative differences in the expression profiles of several
desmosomal proteins (i.e., desmogleins, desmocollins, desmoplakin,
plakoglobin and plakophilin), between these sites. Specifically, a
higher expression level of all five of these proteins, as well as a
respective early expression of involucrin has been demonstrated in
palm skin compared with cultured breast skin keratinocytes.
Morphometric analysis has also shown that, overall, desmosomes are
larger but of similar population density in the palm compared with
breast skin [8]. Although our study results demonstrate no
microscopic blisters in the palms or soles of the El Bagre-EPF
patients, our DIF findings suggest that immunological events in the
palms may be causally associated with the clinical feature of palm
edema in this disorder, and possibly mild palmar hyperkeratosis as
well. Relative to previous immunodermatology studies, we visualized
many similar DIF patterns in our findings, such as ICS and BMZ
staining [9, 10]. However, in addition to these patterns, we
observed immunoreactivity to sweat glands, blood vessels, neural
structures, and both intracytoplasmic and intranuclear staining
within epidermal keratinocytes. For over thirty years,
immunodermatopathology laboratories have predominately analyzed
autoantibodies to IgG, IgM, IgA, C3 and fibrinogen in the
evaluation of pemphigus and bullous pemphigoid, following the
pioneering work of Beutner, Jordon, Chorzelski and others [9, 10].
Notably, albumin, fibrin and fibrinogen represent consistent
immunoreactants in most autoimmune dermatoses, as well as other
inflammatory dermatoses. However, the specific pathophysiological
roles of these proteins have not been extensively evaluated in many
disease processes.
Histologically, skin edema and inflammation are usually
associated with increased porosity and fluid leakage in selected
basement membrane zones [11]. These changes in BMZ barriers enhance
the capacity of fluids and molecules to pass through the BMZ, and
move into affected tissues [11]. During the inflammatory process,
both fibrinogen and fibronectin are deposited in BMZs; their roles
in the leakage phenomenon had previously been interpreted as part
of a healing process [11]. It is also known that chronic
inflammation in a particular tissue is usually accompanied by a
thickening of the BMZ [11]. As the plasma proteins albumin and
fibrinogen pass through the BMZ in large amounts, portions of these
proteins are retained at the BMZ [11]. The retention of these
proteins at the BMZ is well documented in lupus erythematosus [12].
Fibrinogen is an integral component of a primary plasma proteolytic
system involved in coagulation and tissue fluid homeostasis.
Albumin plays sentinel roles in the maintenance of blood and tissue
osmotic pressure, and blood viscosity [11]. In pemphigus and
pemphigoid, and possibly in many other autoimmune skin diseases, at
least one of the four primary plasma proteolytic systems appears to
be consistently affected. The four systems are: 1) the complement
system (e.g., C1q, .C3, and C4) [13-15], 2) the kinin system (e.g.,
kallikrein), 3) the blood coagulation system (e.g., fibrinogen),
and 4) the blood fibrinolytic system (e.g., urokinase-type
plasminogen activator and plasminogen) [13-15]. Albumin serves as
the primary carrier of many of these pathway molecules, and may
also perform a secondary transport function when the primary
carriers are not available [11].
Based on our findings, as well as the current medical
literature, we speculate that both fibrinogen and albumin may play
more than a passive role in the pathophysiology of autoimmune and
other inflammatory skin disorders. In animals, the immunological
role of these proteins may be multifaceted (i.e., as hapten
carriers, co-stimulatory molecules, and/or other functions) [16].
For example, in the equine disease strangles, caused by
Streptococcus equi, S. equi M protein (SeM3), is also known as
fibrinogen binding protein (FgBP) and serves as a major cell
wall-associated protein of S. equi subsp. Equi. The N-terminal
region of FgBP can bind strongly to fibrinogen and thus appears to
play an important part in the anti-phagocytic effect of the
protein, and survival of S. equi in the host In addition to the
binding of host fibrinogen, FgBP has been demonstrated to bind to
the Fc region of equine IgG, as well as IgG from several other
species [16].
In studies of human cell interactions with extracellular
matrices, studies have shown that albumin and other molecules can
alter the matrix biochemical properties, which may in turn affect
the growth and/or morphologic properties of the target cells [17].
We suggest the possibility of a currently uncharacterized,
fluid-based albumin and/or fibrinogen matrix that may allow these
proteins to play such a role in vivo in multiple dermatoses, thus
facilitating the homing of host inflammatory cells into the target
tissues [18, 19].
In our study, we found auto-antibodies from El Bagre-EPF patient
sera directed to the dermal blood vessels (both papillary and
reticular), which co-localized with ICAM-1/CD54 and JAM-A.
ICAM-1/CD54 is present in endothelial cells, and mediates cell
adhesion by binding to Integrin CD11a/CD18 enhancing
antigen-specific T-cell activation. ICAM-1/CD54 also binds to
CD43 and to Plasmodium falciparum-infected erythrocytes, which
themselves display CD36 on their cell surfaces. Interestingly,
El Bagre-EPF patients live in a geographic area endemic for
falciparum malaria [2, 3].
We found DIF auto-reactivity to sweat glands utilizing our El
Bagre EPF patient sera, and we discuss this finding separately
[20]. Notably, the demonstration of HLA-DR reactivity on human
eccrine gland acrosyringia led to our suggestion that eccrine
epithelium might play an active role in the pathophysiological
immune response.
With regard to the neural tissue autoreactivity observed,
previous authors have reported that epidermal nerves were found to
decrease in number in several patients with pemphigus, and these
findings were correlated with histological evidence of nerve
degeneration and degradation, including neural inflammation,
localized neural swelling and demyelinization of neurofibrillar
bundles (Abreu et al., ms submitted) [21]. Other researchers have
also reported nervous system alterations in patients with pemphigus
[22]. Auto-antibodies to acetylcholine receptors have been
previously reported in both pemphigus foliaceus and vulgaris [23].
Based on the literature, [21, 22] and the auto-reactivity to nerves
that we described, we propose that these findings may play a direct
pathophysiological role in the clinical burning sensation reported
by EPF patients (Abreu et al., ms submitted).
Notably, clinical palmar involvement has been described in
patients with pemphigus vulgaris [24, 26]. Palmar immunobullous
disease and acquired PPK have also been reported in a patient with
alterations in desmocollin 3 proteins [25].
Positive IgD deposits were found in a few palms of our El
Bagre-EPF patients. IgD deposits have previously been described in
several cases of pemphigus and BP [27]. Deposits of IgD have also
been described in patients with FS [28]. Of importance is the fact
that the EPF foci occur in areas exposed to multiple tropical
diseases, including malaria, leishmaniasis, hydatidosis,
scuistosomiasis, and trypanosomiasis. Thus, the observed immune
response to IgD might be secondary to concurrent, separate disease
processes, and may or not play a pathogenic role in El Bagre EPF
[2, 3].
Similarly to our findings, the presence of auto-antibodies to
smooth muscle has been reported in paraneoplastic pemphigus and in
pemphigus associated with myasthenia gravis [29, 30]. In addition,
and similarly to our findings, smooth muscle reactivity within
blood vessels has been previously documented in autoimmune skin
disorders [31, 32]. In patients with chronic fogo selvagem, the
presence of palmoplantar hyperkeratosis has been also described
[28].
In summary, we present DIF immunological findings that may
contribute to the pathophysiology of the clinical palmar edematous
texture and mild hyperkeratosis observed in patients affected by El
Bagre-EPF. The full significance of our findings is unknown, and
warrants further investigation. Our findings do not address the
clinical lack of palmoplantar blisters, vesicles and pustules in
the El Bagre-EPF patients, in comparison with other areas of their
skin. We speculate that hair follicles and sebaceous glands (not
present in the palms and soles) may play an essential role in
blister formation in the non-glabrous skin of these patients. We
further suggest that the specific qualities of the glabrous skin
epidermis (i.e., its increased stratum corneum thickness,
potentially thicker keratinocyte cell membranes within the stratum
spinosum, and the additional epidermal stratum lucidum) may play a
critical role in protection against external trauma and that such
traumatic forces may directly contribute to skin vesicle and bulla
formation in patients affected by this disorder.
Acknowledgements
Funding sources: Georgia Dermatopathology Associates (MSH),
Atlanta, Georgia, USA. The El Bagre-EPF samples were collected
through funding from previous grants from the Embassy of Japan in
Colombia, DSSA, Mineros de Antioquia SA, U de A, and Hospital
Nuestra Señora de El Bagre (AMA), Medellin, Colombia, South
America. Conflict of interest: none.
References
1 Hans-Filho G, Dos Santos V, Katayama JH,
et al. An active focus of high prevalence of fogo selvagem on
an Amerindian reservation in Brazil. J Invest Dermatol 1996; 107:
68-75.
2 Abréu-Vélez AM, Beutner E, Montoya F,
et al. Analyses of autoantigens in a new form of endemic
pemphigus foliaceus in Colombia. J Am Acad Dermatol 2003; 49:
609-14.
3 Morini JP, Jomaa B, Gorgi Y, et al.
Pemphigus foliaceus in young women. An endemic focus in the Sousse
area of Tunisia. Arch Dermatol 1993; 129: 69-73.
4 Christiano AM. Frontiers in keratodermas: pushing the
envelope. Trends Genet 1997; 13: 227-33.
5 Uitto JL, Pulkkinen L, Smith FJ, et al.
Plectin and human genetic disorders of the skin and muscle. The
paradigm of epidermolysis bullosa with muscular dystrophy. Exp
Dermatol 1996; 5: 237-46.
6 Wan H, Dopping-Hepenstal PJ, Gratian MJ,
et al. Desmosomes exhibit site-specific features in human palm
skin. Exp Dermatol 2003; 12: 378-88.
7 Mahoney MG, Wang Z, Rothenberger K, et al.
Explanations for the clinical and microscopic localization of
lesions in pemphigus foliaceus and vulgaris. J Clin Invest 1999;
103: 461-8.
8 Keren H, Bergman R, Mizrachi M, Kashi Y,
Sprecher E. Diffuse nonepidermolytic palmoplantar keratoderma
caused by a recurrent nonsense mutation in DSG1. Arch Dermatol
2005; 141: 625-8.
9 Jordon RE, Beutner EH, Witebsky E, et al.
Basement zone antibodies in bullous pemphigoid. J Amer Med Ass
1967; 200: 751-6.
10 Beutner EH, Jordon RE, Chorzelski TP. The
immunopathology of pemphigus and bullous pemphigoid. J Invest
Dermatol 1968; 51: 63-80.
11 Best and Taylor’s. Physiologycal bases of medical practice.
Edited by John B West, 11th edition Williams and
Wilkins, Chapter 20, pages 334-40.
12 Yang S, Gao Y, Song Y, et al. The study
of the participation of basement membrane zone antibodies in the
formation of the lupus band in systemic lupus erythematosus. Int J
Dermatol 2004; 43: 420-7.
13 Rosatelli TB, Roselino AM,
Dellalibera-Joviliano R, et al. Increased activity of
plasma and tissue kallikreins, plasma kininase II and salivary
kallikrein in pemphigus foliaceus (fogo selvagem). Br J Dermatol
2005; 152: 650-7.
14 Grando SA, Glukhen’kiĭ BT, Kostromin AP,
et al. The role of kallikrein-kinin system components in the
pathogenesis of bullous skin lesions in pemphigus and pemphigoid.
Vopr Med Khim 1990; 36: 23-7.
15 Brenner S, Ruocco V, Ruocco E,
Srebrnik A, Goldberg I. A possible mechanism for
phenol-induced pemphigus. Skinmed 2006; 5: 25-6.
16 Lewis MJ, Meehan M, Owen P, et al. A
common theme in interaction of bacterial immunoglobulin binding
proteins with immunoglobulins illustrated in the equine system. J
Biol Chem 2008; 283: 17615-23.
17 Pins GD, Bush KA, Cunningham LP, et al.
Multiphoton excited fabricated nano and micro patterned
extracellular matrix proteins direct cellular morphology. J Biomed
Mater Res 2006; 78: 194-204.
18 Kimura S, Nishikawa T. An immunohistochemical
analysis of the deposited immunoglobulins or fibrinogen in
parakeratotic psoriatic horny layer and pemphigus skin lesions.
Arch Dermatol Res 1978; 261: 55-62.
19 Fyrand O, Mellbye OJ, Larsen TE. Deposition of
fibrinogen (FR-antigen) in skin diseases. II. Pustulosis palmaris
et plantaris (with special reference to heparin-precipitable
fraction). Acta Derm Venereol 1975; 55: 469-74.
20 Abreu-Velez AM, Howard MS, Hashimoto K, Hashimoto T.
Autoantibodies to sweat glands detected by different methods in
serum and in tissue from patients affected by a new variant of
endemic pemphigus foliaceus.Arch Dermatol Res. 2009 Jun 23. [Epub
ahead of print]
21 Torsuev NA, Kimbarovskaia EM, Romanenko VN,
et al. Neuromorphology of the skin in patients with pemphigus
vulgaris. Vestn Dermatol Venerol 1977; 10: 13-7.
22 Tseraidis GS, Bavykina EA. Changes in adrenergic
and cholinergic nerves of the skin in chronic pemphigus. Vestn
Dermatol Venerol 1977; 10: 17-20.
23 Vu TN, Lee TX, Ndoye A, Shultz LD,
et al. The pathophysiological significance of nondesmoglein
targets of pemphigus autoimmunity. Development of antibodies
against keratinocyte cholinergic receptors in patients with
pemphigus vulgaris and pemphigus foliaceus. Arch Dermatol 1998;
134: 971-80.
24 Mascarenhas R, Fernandes B, Reis JP,
Tellechea O, et al. Pemphigus vulgaris with nail
involvement presenting with vegetating and verrucous lesions.
Dermatol Online J 2003; 5: 14.
25 Bolling MC, Mekkes JR, Goldschmidt WF, van
Noesel CJ, et al. Acquired palmoplantar keratoderma and
immunobullous disease associated with antibodies to desmocollin 3.
Br J Dermatol 2007; 157: 168-73.
26 Masala MV, Cozzani E, Rosella M,
Montesu MA. Pemphigus vulgaris on the palms. Eur J Dermatol
1997; 6: 453-4.
27 Cormane RH, Giannetti A. IgD in various dermatoses;
immunofluorescence studies. Br J Dermatol 1971; 84: 523-33.
28 Vieira JP, Fonzari M, Goldman L. Some Recent
Studies in Brazilian Pemphigus. Am J Trop Med Hyg 1954; 5:
868-77.
29 McKee H, McClelland M, Sandford JC.
Co-existence of pemphigus, anti-skeletal muscle antibody and a
retroperitoneal paraganglioma. Br J Dermatol 2006; 99: 441-5.
30 Jablonska S, Chorzelski TP, Lebioda J.
Koexistenz Von. Pemphigus erythematosus and myasthenia gravis.
Hautarzt 1970; 21: 156-60.
31 Miloš D, Pavlović MD, Radoš D Zečević MD. Dermatology Online
J. Cutaneous small-vessel vasculitis with unexpected circulating
and in situ bound pemphigus autoantibodies. 2004 ; 11: 19.
32 Peterson JD, Worobec SM, Chan LS. An
erythrodermic variant of pemphigus foliaceus with puzzling
histologic and immunopathologic features. J Cutan Med Surg 2007;
11: 179-84.
|